Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022

SELL
N/A
-1,100 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
N/A
100 Added 10.0%
1,100 $5,000
Q1 2021

Apr 26, 2021

SELL
N/A
-200 Reduced 16.67%
1,000 $4,000
Q3 2020

Oct 27, 2020

SELL
N/A
-600 Reduced 33.33%
1,200 $4,000
Q1 2020

May 07, 2020

SELL
N/A
-849 Reduced 32.05%
1,800 $5,000
Q4 2019

Feb 06, 2020

BUY
N/A
600 Added 29.28%
2,649 $10,000
Q1 2019

May 10, 2019

SELL
N/A
-300 Reduced 12.77%
2,049 $14,000
Q4 2018

Feb 05, 2019

SELL
N/A
-700 Reduced 22.96%
2,349 $20,000
Q3 2018

Nov 07, 2018

BUY
N/A
500 Added 19.62%
3,049 $61,000
Q2 2018

Aug 10, 2018

BUY
N/A
2,449 Added 2449.0%
2,549 $65,000
Q4 2017

Jan 17, 2018

SELL
N/A
-409 Reduced 80.35%
100 $3,000
Q3 2017

Oct 17, 2017

BUY
N/A
509
509 $10,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.